PepGen
Paul Streck, MD, MBA, currently serves as the Executive Vice President of Research and Development at PepGen. Previously, Paul held the position of Chief Medical Officer at Albireo Pharma, Inc., Arena Pharmaceuticals, Inc., and Alder BioPharmaceuticals, Inc. Additionally, Paul contributed to Pfizer in a role focused on post-merger transition leadership and support. Paul’s educational background includes an MBA from Duke University - The Fuqua School of Business (2000-2002) and a medical degree from Jefferson Health (1991-1997).
This person is not in any teams
This person is not in any offices
PepGen
2 followers
Driven by its proprietary Enhanced Delivery Oligonucleotide (EDO) platform, PepGen is creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.